Clinical Trials Directory

Trials / Conditions / Pancreatic Carcinoma Non-resectable

Pancreatic Carcinoma Non-resectable

7 registered clinical trials studyying Pancreatic Carcinoma Non-resectable.

StatusTrialSponsorPhase
Active Not RecruitingPancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
NCT05642962
Memorial Sloan Kettering Cancer CenterPhase 1 / Phase 2
TerminatedImmunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer
NCT02405585
NewLink Genetics CorporationPhase 2
TerminatedDose Escalation Study of CyberKnife® SBRT Boost for Patients With Unresectable Locally Advanced Pancreatic Can
NCT01872377
Ottawa Hospital Research InstituteN/A
TerminatedImmunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer
NCT01836432
NewLink Genetics CorporationPhase 3
TerminatedStudy to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer
NCT01851174
Western Regional Medical CenterPhase 2
CompletedInduction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic Carcinoma
NCT01593475
National Cancer Center, KoreaPhase 2
CompletedStudy of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer
NCT00761345
Fox Chase Cancer CenterPhase 1